Business · 23/09/2011
FDA Releases Guidance on Assessing Reproductive and Developmental Toxicities for New Drug Applications
The Food and Drug Administration (FDA) has made available a guidance document that provides an approach for estimating potential human developmental or reproductive risks associated with drug exposure, when nonclinical toxicity data is available but human data is not.
Original source language: Federal Register — Health and Human ServicesOpen original release →